The following is a discussion of our financial condition and results of
operations for the years ended December 31, 2022 and 2021, and other factors
that are expected to affect our prospective financial condition. The following
discussion and analysis should be read together with our audited consolidated
financial statements and related notes included in Item 8 Financial Statements
and Supplementary Data of this annual report.



Some of the statements set forth in this section are forward-looking statements
relating to our future results of operations, financial condition, liquidity and
capital resources. Our actual results, financial condition, liquidity and
capital resources may vary from the results anticipated by these statements. We
disclaim any obligation to update or revise any forward-looking statements based
on the occurrence of future events, the receipt of new information, or
otherwise. Actual future results may differ materially from those expressed in
the forward-looking statements as a result of risks, uncertainties and
assumptions. Please see "Cautionary Statement Regarding Forward-Looking
Statements" and Item 1A Risk Factors of this annual report.



Overview



We are workers' compensation cost containment specialists. Our business
objective is to deliver value to our customers that reduces their workers'
compensation related medical claims expense in a manner that will assure injured
employees receive high quality healthcare that allows them to recover from
injury and return to gainful employment without undue delay. Our customers
include self-administered employers, insurers, third party administrators,
municipalities, and others. Our principal customers are companies with
operations located in the state of California where the cost of workers'
compensation insurance is a critical problem for employers, though we process
medical bill reviews, utilization reviews and provide medical case management in
several other states.



Our core services focus on reducing medical treatment costs by enabling our
customers to share control over the medical treatment process of their injured
employees. This control is obtained by participation in one of our medical
provider networks. We realize revenues from enrollment of the employees of our
customers into our various networks. We also provide claims-related services
including utilization review, medical case management, medical bill review, lien
representation, workers' compensation carve-outs, expert witness testimony and
Medicare set-aside services that bring efficiencies to claims processing and
management that reduce the overall burden of workers' compensation claims
resolution.



Our business generally has a long sales cycle, typically eight months or more.
Once we have established a customer relationship and enrolled employees of our
customers, our revenue adjusts with the growth or retraction of our customers'
employee headcount and their number of workers' compensation claims. Throughout
the year, customers' employee headcount and number of claims fluctuate due to
seasonal or operational reasons. New customers are added while others terminate
for a variety of reasons, such as changing workers' compensation insurance
carriers, third party administrators, or their contract term with us ends. Some
of our customers are municipalities and local governmental entities which are
required to go out for bid when their contract with us ends, which affects the
ability for us to negotiation with and retain these types of customers.



As discussed in this annual report, COVID-19 has had and may continue to have an
impact on our business. There was an increase in COVID-19 related claims during
the fourth quarter of 2021 through the beginning of 2022 as businesses reopened
to full capacity. As vaccines have become widely available and herd immunity
increased, the number of COVID-19 related claims decreased through the end of
2022. While the economy recovers from the impacts of COVID-19, long term changes
in workforce trends such as downsizing and remote work, along with the effects
of recent economic downtrends, could continue to adversely affect the number of
workers' compensation claims and could materially affect our results of
operations.



We expect businesses will continue to seek ways to control their workers'
compensation program costs. While our HCO and MPN programs have been shown to
create a favorable return on investment for our customers, (as our services are
a significant component of our customers' loss prevention programs), from time
to time we experience customer volatility in the form of existing customers
terminating or seeking to renegotiate the scope and terms of existing services,
switching to a third party administrator or insurance company that provides the
same services as ours, or seeking to reduce costs by managing their workers'
compensation care services in-house.



                                       23

--------------------------------------------------------------------------------

Table of Contents

Impact of COVID-19 on our Business





In February 2022, California passed another COVID-19 Supplemental Paid Sick
Leave law ("CSPSL"). It provided employees paid leave for COVID-19 related
reasons such as caring for themselves, family members, or for vaccine related
appointments or illnesses caused by COVID-19 or the vaccine from January 1, 2022
through September 30, 2022. The CSPSL allowed employees to retroactively request
reimbursement for qualifying leave or to use it towards future requests through
September 30, 2022. Employers whose employees utilized CSPSL are ineligible for
federal tax credits to offset the costs of providing the CSPSL. On September 29,
2022, California passed a bill that extended the CSPSL leave through December
31, 2022 and provides a supplemental paid sick leave relief grant program for
employers for reimbursement of CSPSL. As of the date this report is released,
the CSPSL relief grant program is still in development and unavailable to apply
for. When it becomes available, we intend to apply for the reimbursement of
CSPSL.



We continued to offer COVID-19-specific paid leave benefits to our employees
until the expiration of CSPSL on December 31, 2022, although we continue to have
family, medical, and other types of leave available to employees under
pre-existing Company policy. As of December 31, 2022, we have incurred
negligible payroll, benefits, administrative, and liability costs related to
CSPSL. As of the date of this report, California has not passed additional
COVID-19 related sick leave laws.



Unlike much of the U.S. economy, we have maintained relatively steady employee
recruitment and retention. Our maintenance of a successful remote environment,
including high employee morale and cohesive culture via technology, has also
allowed us to seek candidates in a wider range of locations, some of which have
lower costs of living and lower wage norms, as well as increasing the quantity
of qualified applicants. While we cannot predict or control future trends in
labor in our industry, we believe that our solid recruitment practices and the
opportunities presented by remote work options will help us adapt to a changing
workforce environment.



In response to COVID-19 and transitioning to a remote workforce, we have taken
measures to ensure data security, but there is no guarantee that these measures
will be completely effective, that our productivity will not be adversely
impacted, or that we will not encounter other risks associated with a remote
workforce, such as increased loss of direct control of and reliance on third
party information systems required for us to run our business. As discussed in
greater detail in Item 1A Risk Factors of this annual report, our business has
been and could continue to be materially and adversely affected by the potential
interruptions to our business operations resulting from changes to our business
model in response to COVID-19.



Summary of Fiscal 2022



During the year ended December 31, 2022, total revenues increased 6%. Revenue
from HCO, MPN, medical bill review and utilization review revenue increased by
4%, 2%, 12% and 50%, respectively. Revenue from medical case management and
other fees decreased 15% and 25%, respectively. During the first quarter of
fiscal 2022, we saw an increase in revenue from HCO, MPN, medical bill review,
and utilization review. Some of the increases were due to increases in COVID-19
related claims in the first quarter of 2022, but they declined throughout the
remainder of fiscal 2022. We expect that as COVID-19 related claims and any
backlogs of medical treatment for which we would perform medical bill review,
utilization review, and medical case management will decrease, but will level
out to pre-pandemic levels as the economy recovers.



During fiscal 2022, operating expenses increased by 4%, primarily as a result of
increases in professional fees, outsource service fees, and general and
administration expenses. The increases were partially offset by decreases in
depreciation, bad debt provision, consulting fees, salaries and wages,
insurance, and data maintenance expenses. As a result, our income from
operations increased 29% to $666,124 in fiscal 2022 compared to $516,475 during
fiscal 2021.


Our provision for income tax expense remained flat during fiscal 2022, from $201,055 in fiscal 2021 to $200,437 in fiscal 2022, as a result of the Paycheck Protection Program loan forgiveness income being tax-exempt.





Our net income decreased 50% from $995,020 in fiscal 2021 to $492,886 in fiscal
2022, primarily as a result of the Paycheck Protection Program loan forgiveness
income we received in 2021, partially offset by a 6% increase in total revenues.
Basic and fully diluted earnings per share during fiscal 2022 was $0.04 and
$0.04, respectively, compared to $0.08 and $0.08, respectively, during fiscal
2021.



                                       24

--------------------------------------------------------------------------------


  Table of Contents



Revenue


We derive revenue primarily from fees charged for access to our HCO and MPN provider networks, claim network fees, HCO/MPN network administration, medical bill review, utilization review, medical case management services, Medicare set-asides, and network access.





HCO



HCO revenue is generated largely from fees charged to our employer customers for
claim network fees to access to our HCO networks, employee enrollment into our
HCO program, program administration, custom network fees, annual and new hire
notifications, and fees for other ancillary services they may select.



MPN



Like HCO revenue, MPN revenue is generated largely from fees charged to our
employer customers for claim network fees to access our MPN networks, custom
network fees, and program administration. Unlike HCOs, MPNs do not require
annual and new hire notifications, MPNs are only required to provide a notice to
an injured employee at the time the employer is notified by the injured employee
that an injury occurred.



Medical bill review



California and many other states have established fee schedules for the maximum
allowable fees payable under workers' compensation for a variety of procedures
performed by medical providers. Many procedures, however, are not covered under
the fee schedules, such as hospital bills, which still require review and
negotiation. Medical bill review involves analyzing medical provider services
and equipment billing to ascertain proper reimbursement. Such services include,
but are not limited to, coding review and re-bundling, confirming that the
services are customary and reasonable, fee schedule compliance, out-of-network
bill review, pharmacy review, and preferred provider organization repricing
arrangements. Our medical bill review services can result in significant savings
for our customers. Revenue for medical bill reviews is generated based on a set
fee per medical bill reviewed. Hospital bills generate revenue on a percentage
of savings off the original amount, usually with a cap on the max amount we can
charge for a hospital bill.



Utilization review



Utilization review is the review of medical treatment requests by providers to
provide a safeguard for employers and injured employees against unnecessary and
inappropriate medical treatment from the perspective of medical necessity,
quality of care, appropriateness of decision-making, and timeliness of
treatment. Its purpose is to reduce employer liability for medical costs that
are not medically appropriate or approved by the relevant medical and legal
authorities and the payor. We generate revenue when we receive a request for
authorization of treatment from a claims adjuster. We bill by the number of
treatment requests or by referral and the level of reviewer required to approve,
modify, or deny the request.



The following table sets forth, for the years ended December 31, 2022 and 2021,
the percentage each revenue item identified in our audited consolidated
financial statements contributed to total revenue during the respective period.



                          2022      2021
HCO                          26 %      27 %
MPN                           9 %      10 %
Medical bill review           7 %       7 %
Utilization review           29 %      20 %
Medical case management      26 %      33 %
Other                         3 %       3 %




Expense



Consulting fees


Consulting fees include fees we pay to third parties for IT, marketing, and in-house legal advice for the various services we offer.


                                       25

--------------------------------------------------------------------------------


  Table of Contents



Salaries and wages


Salaries and wages reflect employment-related compensation we pay to our employee, payroll processing, payroll taxes and commission.





Professional fees


Professional fees include fees we pay to third parties to provide medical consulting, field medical case management, and board of director's fees for board meetings, as well as legal and accounting fees.





Insurance



Insurance expense is comprised primarily of health insurance benefits offered to
our employees, directors' and officers' liability insurance, cyber security,
Workers' Compensation coverage and business liability coverage.



Data maintenance fees



Data maintenance fees includes fees we pay to a third party to process HCO and
MPN employee enrollment and host our HCO and MPN provider networks. HCO and MPN
employee enrollment fees fluctuate throughout the year because of the varied
timing of customer enrollment into the HCO or MPN program, the number of
employees they have in their workforce, and the number of new hires throughout
the year.



Outsource service fees



Outsource service fees consist of costs incurred by our subsidiaries in
partially outsourcing utilization review, medical bill review, administrative
services for medical case management and Medicare set-aside services and
typically tend to increase and decrease in correlation with customer demand for
those services.



General and administrative



General and administrative expenses consist primarily of office rent,
advertising, dues and subscriptions, equipment/repairs, IT enhancement, licenses
and permits, telephone, office supplies, parking, postage, printing and
reproduction, rent expense for equipment, miscellaneous expenses, shareholders'
expense, charity - cash contribution, auto expenses, bank charges, education,
travel and entertainment, and vacation expense.



The following table sets forth, for the years ended December 31, 2022 and 2021,
the percentage each expense item identified in our audited consolidated
financial statements contributed to total expense during the respective period.



                             2022      2021
Depreciation                     1 %       1 %
Bad debt provision               - %       - %
Consulting fees                  4 %       5 %
Salaries and wages              53 %      56 %
Professional fees                6 %       6 %
Insurance                        6 %       7 %
Outsource service fees          12 %       7 %
Data maintenance                 4 %       4 %
General and administrative      14 %      14 %




                                       26

--------------------------------------------------------------------------------


  Table of Contents



Results of Operations


Comparison of the fiscal years ended December 31, 2022 and 2021

The following represents selected components of our consolidated results of operations, for the years ended December 31, 2022 and 2021, respectively, together with changes from year-to-year:





                                     Year Ended December 31,
                                                                     Amount of
                                       2022            2021            Change         % of Change
Revenues:
HCO                                $  1,500,363     $ 1,449,345     $     51,018                 4 %
MPN                                     534,447         524,148           10,299                 2 %
Medical bill review                     412,015         368,721           43,294                12 %
Utilization review                    1,636,632       1,091,792          544,840                50 %
Medical case management               1,513,659       1,771,718         (258,059 )             (15 %)
Other                                   147,841         197,386          (49,545 )             (25 %)
Total revenues                        5,744,957       5,403,110          341,847                 6 %

Expenses:
Depreciation                             33,998          48,887          (14,889 )             (30 %)
Bad debt provision                         (626 )        15,656          (16,282 )            (104 %)
Consulting fees                         227,406         237,582          (10,176 )              (4 %)
Salaries and wages                    2,689,842       2,740,806          (50,964 )              (2 %)
Professional fees                       314,013         293,936           20,077                 7 %
Insurance                               315,919         321,690           (5,771 )              (2 %)
Outsource service fees                  610,277         364,951          245,326                67 %
Data maintenance                        182,437         204,725          (22,288 )             (11 %)
General and administrative              705,567         658,402           47,165                 7 %
Total expenses                        5,078,833       4,886,635          192,198                 4 %

Income from operations                  666,124         516,475          149,649                29 %

Other income (expense):
Paycheck Protection Program loan
forgiveness income                            -         684,785         (684,785 )            (100 %)
Paycheck Protection Program loan
interest expense                              -          (5,185 )          5,185              (100 %)
Interest income                          27,199               -           27,199               100 %
Total other income (expense)             27,199         679,600         (652,401 )             (96 %)

Income before taxes                     693,323       1,196,075         (502,752 )             (42 %)
Income tax provision                    200,437         201,055             (618 )               - %

Net income                         $    492,886     $   995,020     $   (502,134 )             (50 %)




                                       27

--------------------------------------------------------------------------------

Table of Contents

Key trends affecting results of operations





As noted throughout this annual report, during the years ended December 31, 2022
and 2021, COVID-19 has impacted the businesses of our customers, our business,
and our results of operations. Most of our clients, and their employees are
located in California. Throughout 2020 and for periods of 2021, California had
in place COVID-19 restrictions on businesses which resulted in many of our
customers reducing their workforces and caused a decrease in the number of new
workers' compensation claims, as a result of fewer workers working. Allowable
medical treatment for workers' compensation claims were also limited to help
ease the burden of COVID-19 on medical facilities. During the first nine months
of 2022, as the economy reopened, employers began hiring, but given the recent
economic downturn, some employers reduced their workforce in the fourth quarter
of 2022. If the economy continues a downward trend and our customers reduce
their workforce, revenues would be adversely affected.



Our revenues for medical case management were also impacted since the start of
the pandemic in 2020 through 2022. Workers' compensation claims that require
medical case management are usually severe or litigated and may take anywhere
from a few days up to years to come to resolution. As a result of COVID-19
related business and office closures, there were fewer workers' compensation
claims during those years, which would have potentially generated revenues in
the following years. If the trend to smaller labor pools continues, medical case
management reviews could continue to remain lower in the future.



During the fourth quarter of 2022, we experienced difficulties when
transitioning to a new software vendor for our utilization review and medical
case management services. The initial new software platform was not fully
functional, which resulted in us terminating that agreement and contracting with
another software vendor.  Throughout these software transitions, our automated
processes had to be performed manually, which caused delays in providing
services and invoicing our customers, reduced productivity and resulted in
additional outsourcing costs. Our revenues were adversely impacted in the fourth
quarter of 2022 as a result of the interruptions and costs associated with these
software transition difficulties.  While the new software is now near fully
functional, certain functionalities are still being developed and we continue to
experience delays in invoicing several of our customers, which has resulted in
an increase in our outstanding accounts receivable.  We anticipate the software
to become fully functional, but expect some degree of continued delays in
invoicing customers.



We were recently notified that Fortra, LLC, the third-party vendor that provides
the GoAnywhere managed file transfer as a service system (MFTaaS), experienced a
data security incident that affected many of Fortra's customers, including the
Company.  The Company uses GoAnywhere as a means by which our customers
electronically share certain data regarding their employees and other third
parties with the Company. Based on the information we have obtained from Fortra
and our own diligence, we understand that this activity only affected Fortra's
systems, and did not involve unauthorized access into the Company's information
systems. Our current understanding is that this activity was the result of the
threat actor's exploit of a zero-day vulnerability in Fortra's systems. Through
this exploit, the threat actor created unauthorized user accounts for certain
customer MFTaaS, including that of the Company.



Upon receiving notification of this incident, we began an investigation with the
assistance of outside experts. Through our investigation, we have learned that
this incident included the unauthorized access to and exfiltration of data in
the Company's GoAnywhere account. While the investigation is ongoing, early
indications are that the threat actor accessed certain of our customers'
employees' and other third parties' data from January 28 to January 31, 2023.
Such data likely includes protected health information, as defined by the Health
Insurance Portability and Accountability Act ("PHI"), and personal information
("PI"). Our current understanding is that the threat actor exfiltrated
approximately 900 gigabytes of data. We are continuing our investigation to
determine the contents of the exfiltrated data and the individuals to whom the
PI/PHI, if any, belongs.



As of the date of this annual report, this incident has not caused a material
interruption of our business operations.  To the extent we discover further
details of this incident and data accessed, we will provide the appropriate
notifications to any individuals affected by the incident, as well as to
government and regulatory agencies as required by federal and state law. Because
of the preliminary nature of our investigation into this incident and current
unknowns, an estimate of the impacts on our business, results of operations and
other potential liabilities, cannot be made.



Revenue



HCO



During the year ended December 31, 2022, HCO revenue increased by 4%. The
increase in HCO revenue was attributable to increases in the number of new
claims and employees enrolled in our HCO program with existing customers, but
was partially offset by decreases in the number of new claims and monthly
program administration fees from the loss of two customers in the fourth quarter
of 2021. In the first quarter of 2022, we had an increase in the number of
COVID-19 related claims; however, if the use of vaccines and herd immunity
continues to increase, or if state and federal legislation declassifies COVID-19
as a workers' compensation claim, we expect the number of COVID-19 related
claims to decrease.



                                       28

--------------------------------------------------------------------------------


  Table of Contents



MPN



There was a 2% increase in MPN revenue for fiscal 2022 compared to fiscal 2021,
primarily from increases in the number of new claims and increases in our
customers' employee headcount by existing customers, which led to in an increase
in the number of MPN claim network fees and monthly program administration fees.
In the first quarter of 2022, we had an increase in the number of COVID-19
related claims; however, if the use of vaccines and herd immunity continues to
increase, or if state and federal legislation declassifies COVID-19 as a
workers' compensation claim, we expect the number of COVID-19 related claims to
decrease.



Medical bill review


There was a 12% increase in medical bill review revenue during fiscal 2022 compared fiscal 2021. The increase was due to an increase in hospital and non-hospital bills reviewed and the addition of a new customer in the fourth quarter of 2022, but was partially offset by the loss of two customers in 2021.





Utilization review



During the year ended December 31, 2022, utilization review revenue increased
50%. The increase in utilization review revenue was due to the addition of a new
customer in each of the fourth quarter of 2021 and the fourth quarter of 2022,
but was partially offset by the loss of a customer in the fourth quarter of
2021, and delays in providing such services and invoicing stemming the software
transition problems in the fourth quarter of 2022. We expect that the growth in
utilization review due to the addition of the new customer will continue in the
future but may decrease to the degree that utilization reviews were due to the
pause on medical treatment during the COVID-19 shutdown. Additionally, as we
resolve the disruptions stemming from difficulties and inefficiencies in
transitioning to new operational software, we anticipate we will be able to
increase our productivity in conducting and invoicing for utilization review
services.



Medical case management



During the twelve-month period ended December 31, 2022, revenue from medical
case management decreased 15% primarily due to disruptions stemming from
difficulties and inefficiencies in transitioning to new operational software,
the loss of a customer in the fourth quarter of 2022, a decrease in the number
of new claims, and fewer claims from the prior years which may have carried over
into 2021 and 2022. In 2021 and 2022, the decrease in the number of new claims
was largely due to the reduction in our customers' workforce and other effects
of COVID-19 business restrictions that reduced the number of new workplace
injuries. With fewer employees in the workforce, it led to a decrease in the
number of new workplace injuries. Claims that occur in one year may continue to
be open for several months to years due to the severity of the injury and
litigation, and the resulting medical case management revenues can carry over to
subsequent fiscal periods. Conversely, a reduction in claims revenues in one
period can result in a reduction of related revenues in the following period. As
such, the reduction in the number of claims in 2021, resulted in a decrease in
medical case management revenue in 2022. Further, the ability for us to provide
medical case management services was interrupted by the software transition
problems we experienced in the fourth quarter of 2022, which adversely affected
our medical case management revenues during the fourth quarter of fiscal 2022.
However, we anticipate an increase of productivity in conducting and invoicing
for medical case management services, as we continue to resolve problems
stemming from the software transition.



Other



Other fees consist of revenue from network access fees derived from out of
network referrals to our network of providers, claims fees, expert witness
testimony, lien representation, legal support services, Medicare set-aside, and
workers' compensation carve-out services.  Other fee revenue for the year ended
December 31, 2022, decreased 25% when compared to the same period a year
earlier. The decrease was the result of a loss of a customer which reduced our
claims fees for accessing our network, as well as decreases in the number of
referrals for Medicare set-aside. The claims fees generated by accessing our
network are no longer offered in the current marketplace and we discontinued
this service in 2021, and as a result we expect other revenues to continue to be
adversely impacted.



Expense



Depreciation


Depreciation expense decreased 30% during fiscal 2022 due to our disposing of fully depreciated fixed assets when we moved office locations.


                                       29

--------------------------------------------------------------------------------


  Table of Contents



Professional fees



Professional fees increased 7% during fiscal 2022. The increase in professional
fees was primarily the result of fees incurred for board of director's fees and
field medical case management services, as well as increases for accounting,
legal, and medical consultants.



Outsource service fees



Outsource service fees increased 67% during the twelve-month period ended
December 31, 2022. The increase was primarily the result of increases in the
number of utilization review referrals and medical bill reviews, as the
provision of those services requires outsourcing. The increases in the volume of
utilization review and medical bill reviews were partially due to injured
employees seeking delayed medical treatment for injuries that occurred during
the pandemic when medical treatment was restricted, the addition of new
customers, as well new workplace injuries. The increased volume in these
services required us to increase our usage of these outsourced services. The
increase of outsourced service fees was partially offset by decreases stemming
from decreased medical case management administrative services and referrals
sent out for Medicare set-aside arrangements, the provision of which also
involves outsourcing. We anticipate our outsource service fees will continue to
move in correspondence with the level of medical bill review, utilization
review, certain medical case management services and Medicare set-aside services
we provide in the future.



Salaries and wages



Salaries and wages decreased 2% during the fiscal 2022 compared to fiscal 2021.
The decrease was due to the loss of a management level employee in the third
quarter of 2022, which was partially offset by increases in wages and salaries
for existing employees. Given the current increased wage inflation trends, we
expect salaries and wages will increase in future periods from our efforts to
attract and retain employees.



Data maintenance



During the year ended December 31, 2022 data maintenance fees decreased 11%
compared to fiscal 2021. The data maintenance fees decrease was due to decreases
in our customers' employee counts for enrollment into our HCO, which resulted in
decreases to correlated data maintenance fees. The decrease was offset by
increases in our customers' employee counts for their monthly program
administration fees.



General and administrative



During fiscal 2022, general and administrative expenses increased by 7% compared
to fiscal 2021. This increase was the result of increases in advertising and
marketing, dues and subscriptions, education, equipment/repairs, IT enhancement,
miscellaneous expenses, parking, and travel and entertainment. The increases
were partially offset by decreases in charity - cash contribution, auto
expenses, bank charges, licenses and permits, office supplies, postage, printing
and reproduction, rent expense for equipment, shareholders' expense, office
rent, telephone and vacation expense. These changes in general and
administrative expenses were largely attributable to changes in how we conducted
our business in response to COVID-19. While we anticipate certain general and
administrative expenses will remain lower in the long-term, such as office rent,
internet and phone, as a result of changes to our business operations in
response to COVID-19, we expect other general and administrative expenses, such
as IT enhancements, hardware and other technology-related expenses will remain
at higher than historic levels in future periods.



Income from Operations


The 6% increase in revenue during fiscal 2022 was partially offset by a 4% increase in total expenses during the same period, resulting in a 29% increase in income from operations during the fiscal year ended December 31, 2022.





Other Income (Expense)



In February 2021, the principal and interest on the Paycheck Protection Program
("PPP") loans in the aggregate amount of $460,700 (the "first draw PPP loans")
issued to PHCO, MMC and MMM in April and May 2020 were forgiven in full. In
December 2021, the principal and interest on the section 311 of the Economic Aid
Act Paycheck Protection Program Second Draw Loans in the amount of $218,900 (the
"second draw PPP loan") issued to MMM in April 2021, were also forgiven in full.
As a result, we realized income from Paycheck Protection Program loan
forgiveness of $684,785 and loan interest expense from the Paycheck Protection
Program loans of $5,185 during the year ended December 31, 2021, resulting in
total other income during 2021 of $679,600.



                                       30

--------------------------------------------------------------------------------

Table of Contents





On December 8, 2022, the Company purchased $8,721,310 of U.S. Treasury bills and
at December 31, 2022, we had interest income of $27,199 compared to $0 during
fiscal year 2021. We do not expect there to be further similar forgivable loans
in future periods and as a result, we expect other income (expense) to continue
to be significantly less in future periods than during the year ended December
31, 2021.



Income Tax Provision



Our income tax provision for the year ended December 31, 2022, remained flat
compared to the same period in 2021. In 2021, the Paycheck Protection Program
income of $679,600 was allowed to be excluded from state and federal income tax.



Net Income



Our total revenues increased 6% during 2022, which was partially offset by a 4%
increase in expenses. Total other income and expenses decreased 96%, as a result
of the recognition in 2021 of PPP loan forgiveness income. The decrease in other
income resulted in a 50% decrease in net income during the year ended December
31, 2022, compared to the year ended December 31, 2021. We do not expect this to
recur in future periods and expect net income to increase or decrease in future
periods largely in correlation with our income from operations.



Liquidity and Capital Resources





Liquidity is a measurement of our ability to meet our potential cash
requirements for general business purposes. We consistently monitor our
liquidity and financial position and take actions management believes are in the
best interest of our Company and our shareholders to ensure the long-term
financial viability of our Company. Historically, we have realized positive cash
flows from operating activities, which, coupled with positive reserves of cash
on hand, have been used to fund our operating expenses and obligations. In prior
years, the company has not engaged in financing activities, but on December 8,
2022, we purchased $8,721,310 in U.S. Treasury bills with a maturity date of
June 8, 2023, to obtain a better rate on our cash reserves. As of December 31,
2022, we had $2,036,432 in cash available, which we believe is enough to support
normal operating expenses and meet our obligations until the bills mature.
However, we cannot assure that we will not encounter circumstances prior to the
bills maturing that require additional cash or related financing, such as
acquisition opportunities.



During fiscal 2021, we experienced declining revenues as a result of the impacts
of the COVID-19 pandemic on our business, the businesses of our customers and
the overall economy. In April and May 2020, PHCO, MMM and MMC received first
draw PPP loans in the aggregate amount of $460,700. In the spirit of the PPP
loan program policy of protecting the continued economic stability of employees,
we put virtually all of the PPP loan amounts toward payroll and employee benefit
expenses. In February 2021, PHCO, MMC, and MMM received full forgiveness of
their first draw PPP loans including accrued interest. In April 2021, MMM
received the second draw PPP loan in the amount of $218,900. The second draw PPP
loan was also used to pay for qualifying expenses, such as payroll, group health
benefits, rent and utilities. In December 2021, MMM received full forgiveness of
the second draw PPP loan including accrued interest.



In addition to availing the Company of the benefits of these government
sponsored programs, we have focused on reducing other operating expenses while
maintaining our ability to provide the high-quality services to which our
customers are accustomed. In April 2022, our office lease in Newport Beach,
California expired and we entered into a 12-month lease on April 1, 2022 in
Irvine, California. In December 2022, we renewed our office lease for an
additional 12-month period which will expire March 31, 2024. As a result of
relocating to a smaller office and continuing to have our employees work
remotely, we have decreased the operating costs for office expenses, but have
utilized some of those savings to enhance our IT security as well as other IT
enhancements.



We realized a net gain of $492,886 as a result of an increase in revenues. As of
December 31, 2022, we had $2,036,432 cash on hand compared to $10,085,372 at
December 31, 2021. The $8,048,940 decrease in cash on hand was the result of net
cash used in investing activities, partially offset by net cash provided by
operating activities. In December 2022, we purchased $8,721,310 of U.S. Treasury
bills, which mature on June 8, 2023. Management currently believes that absent
(i) any unanticipated further COVID-19 impact, (ii) a longer-term downturn in
the general economy as a result of inflation and the sanctions, countermeasures
and other actions in response to the Russia-Ukraine conflict, or (iii) the loss
of several major customers within a condensed period, cash on hand and
anticipated revenues from operations will be sufficient to cover our operating
expenses for at least the next twelve months.



We currently have planned certain capital expenditures to replace our laptops
due to their age and as part of our ongoing continuity plan. We anticipate
investing activities will continue throughout 2022 as we replace aging software,
computer equipment, and further enhance our IT security. We anticipate these
costs to be significant, but believe we have adequate capital on hand to cover
these expenses. We do not anticipate these expenditures will require us to seek
outside sources of funding.



                                       31

--------------------------------------------------------------------------------

Table of Contents





We had a decrease in cash on hand in fiscal 2022 from our investment in U.S.
Treasury bills that will mature on June 8, 2023. We intend to continue to pursue
potential acquisition transactions that, if additional cash on hand were needed
for such transaction, we would either need to condition closing upon maturity of
the bills or seek alternate financing, or a combination of those approaches. We
may also seek growth through organic development of new lines of business or
expansion of existing offerings. Depending upon the nature of the opportunities
we identify, such acquisitions or expansion could require greater capital
resources than we currently possess. Should we need additional capital
resources, we could seek to obtain such through debt and/or equity financing. We
do not currently possess an institutional source of financing and there is no
assurance that we could be successful in obtaining equity or debt financing when
needed on favorable terms, or at all. We could also use shares of our capital
stock as consideration for a business acquisition transaction, but there is also
no assurance that there would be significant interest in our capital stock by a
potential seller or the market.



As a result of the unique nature of the COVID-19 pandemic and its impacts on our
operations, the operations of our customers and the broader economy, coupled
with uncertainty surrounding the potential impacts rising inflation and the
Russia-Ukraine conflict could have, we cannot provide any assurance that the
assumptions management has used to estimate our liquidity requirements will
remain accurate in either the short-term or the longer-term. The ultimate
duration and impact of these events on our business, results of operations,
financial condition and cash flows is dependent on future developments, which
are uncertain, largely beyond our control and cannot be predicted with any
degree of certainty at this time. However, we expect that our results of
operations, including revenues, in future periods will continue to be adversely
impacted by the COVID-19 pandemic and potentially by rising inflation and the
Russia-Ukraine conflict, and their negative effects on economic conditions.



Cash Flow



During the year ended December 31, 2022, cash was primarily used to fund
operations. We had a net decrease in cash of $8,048,940 and net increase of cash
of $586,915 during the years ended December 31, 2022 and 2021, respectively. See
below for additional, discussion and analysis of cash flow.



                                              Year Ended December 31,
                                                 2022            2021

Net cash provided by operating activities $ 711,237 $ 386,391 Net cash used in investing activities

           (8,760,177 )     (18,376 )
Net cash provided by financing activities                -       218,900
Net (decrease) increase in cash             $   (8,048,940 )   $ 586,915




Net cash provided by operating activities was $711,237 and $386,391 in fiscal
2022 and fiscal 2021, respectively. The increase of $324,846 in net cash
provided by operating activities was the result of realizing an increase in net
income coupled with increases in accounts receivable, prepaid expenses, deferred
taxes, accounts payable, accrued expenses, and income tax payable. The increases
were partially offset with decreases in income tax receivable, deferred rent
assets, bad debt provision and other assets.



Net cash used in investing activities was $8,760,177 and $18,376 in fiscal 2022
and fiscal 2021, respectively. Net cash used in investing activities increased
by $8,741,801 in 2022 because of an increase in purchases of computers and
equipment and the purchase of U.S. Treasury bills with a maturity date of June
8, 2023.



In fiscal 2022, net cash used in financing activities was $0, compared to net
cash provided by financing activities of $218,900 in fiscal 2021, stemming from
a second draw PPP loan issued to MMM in the amount.



Off-Balance Sheet Financing Arrangements

As of December 31, 2022, we had no off-balance sheet financing arrangements.





Inflation



We experience pricing pressures in the form of competitive pricing. Insurance
carriers and third-party administrators often try to take our customers by
offering bundled claims administration services with their own managed care
services at a lower rate. We are also impacted by rising costs for certain
inflation-sensitive operating expenses such as labor and employee benefits and
facility leases. We believe that these impacts can be material to our revenues
or net income. Some of our customers are public entities which contract with us
at a fixed price for the term of the contract. Increases in labor and employee
benefits can reduce our profit margin over the term of these contracts. See also
"the effects of inflation may have a disproportionate impact on our business" of
Item 1A Risk Factor of this annual report.



                                       32

--------------------------------------------------------------------------------

Table of Contents

Critical Accounting Policies and Estimates





Our consolidated financial statements are prepared in accordance with accounting
principle generally accepted in the United States ("GAAP"). Application of these
principles requires us to make estimates, assumptions, and judgments that affect
the amounts reported in our consolidated financial statements and accompanying
notes. We continually evaluate our accounting policies, estimates, and judgments
and base our estimates and judgments on historical experience and various other
factors that we believe to be reasonable under the circumstances. Because of the
inherent uncertainty in making estimates and judgments, actual results could
differ from our estimates and judgments. We consider (i) revenue recognition,
(ii) leases, (iii) allowance for uncollectible accounts, and (iv) income taxes
to be the most critical accounting policies because they relate to accounting
areas that require the most subjective or complex judgments by us, and, as such,
could be most subject to revision as new information becomes available.



Leases: We determine if an arrangement includes a lease at inception.
Right-of-use assets represent our right to use an underlying asset for the lease
term; and lease liabilities represent our obligation to make lease payments
arising from the lease. Right-of-use assets and lease liabilities are recognized
at the commencement date of the lease, renewal date of the lease or significant
remodeling of the lease space based on the present value of the remaining future
minimum lease payments. Leases with a term greater than one year are recognized
on the balance sheet as right-of-use assets and short-term and long-term lease
liabilities, as applicable.



Operating lease liabilities and their corresponding right-of-use assets are
initially recorded based on the present value of lease payments over the
expected remaining lease term. The interest rate implicit in lease contracts is
typically not readily determinable. As a result, we utilize our incremental
borrowing rate to discount lease payments, which reflects the fixed rate at
which we could borrow on a collateralized basis the amount of the lease payments
in the same currency, for a similar term, in a similar economic environment. Our
leases may include options to extend or terminate the lease which are included
in the lease term when it is reasonably certain that we will exercise any such
options. Lease expense for lease payments is recognized on a straight-line basis
over the lease term.



Allowance for Uncollectible Accounts: We determine our allowance for
uncollectible accounts by considering a number of factors, including the length
of time trade accounts receivable are past due, our previous loss history, the
customers' current ability to pay its obligation to us, and the condition of the
general economy and the industry as a whole. We write off accounts receivable
when they become uncollectible.



We must make significant judgments and estimates in determining contractual and
bad debt allowances in any accounting period. One significant uncertainty
inherent in our analysis is whether our past experience will be indicative of
future periods. Although we consider future projections when estimating
contractual and bad debt allowances, we ultimately make our decisions based on
the best information available to us at the time the decision is made. Adverse
changes in general economic conditions or trends in reimbursement amounts for
our services could affect our contractual and bad debt allowance estimates,
collection of accounts receivable, cash flows, and results of operations. At
December 31, 2022, two customers accounted for 10% or more of accounts
receivable compared to three customers at December 31, 2021.



Accounting for Income Taxes: We record a tax provision for the anticipated tax
consequences of our reported results of operations. The provision for income
taxes is computed using the asset and liability method, under which deferred tax
assets and liabilities are recognized for the expected future tax consequences
of temporary differences between the financial reporting and tax bases of assets
and liabilities, and for operating losses and tax credit carryforwards. Deferred
tax assets and liabilities are measured using the currently enacted tax rates
that apply to taxable income in effect for the years in which those tax assets
are expected to be realized or settled. We record a valuation allowance, if
necessary, to reduce deferred tax assets to the amount that is believed more
likely than not to be realized.



We recognize tax benefits from uncertain tax positions only if it is more likely
than not that the tax position will be sustained on examination by the taxing
authorities, based on the technical merits of the position. The tax benefits
recognized in the financial statements from such positions are then measured
based on the largest benefit that has a greater than 50% likelihood of being
realized upon ultimate settlement.



Management believes it is more likely than not that forecasted income, including
income that may be generated as a result of certain tax planning strategies,
together with future reversals of existing taxable temporary differences, will
be sufficient to fully recover the deferred tax assets. In the event we
determine all, or part of the net deferred tax assets are not realizable in the
future, we will make an adjustment to the valuation allowance that would be
charged to earnings in the period such determination is made. In addition, the
calculation of tax liabilities involves significant judgment in estimating the
impact of uncertainties in the application of GAAP and complex tax laws.
Resolution of these uncertainties in a manner inconsistent with management's
expectations could have a material impact on our financial condition and
operating results. The significant assumptions and estimates described above are
important contributors to our ultimate effective tax rate in each year.

© Edgar Online, source Glimpses